Breast Implants Market Outlook to 2027: Allergan, Mentor Worldwide LLC, Sientra Inc., Ideal Implant Incorporated, Silimed Indústria de Implantes

The global breast implants market accounted to US$ 1,475.7 Mn in 2018 and is expected to grow at a CAGR of 5.4% during the forecast period 2019 – 2027, to account to US$ 2,338.6 Mn by 2027.

The global breast implants market is a matured market in the developing countries as well as developing economies worldwide. The advancement cosmetic procedures is constantly increasing in recent days due to the advantages of the breast implants such as light weighted, smooth & textured shells and lower risk of complications. Among the applications, the demand for breast implants is significantly high in cosmetic procedures followed by reconstructive surgery. Furthermore, advancements in surgical technologies and declining cost of procedures is expected to be a drive the growth of the breast implants market.

Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPHE100000849/?opr-ss

North America was the leading geographic market and it is anticipated to be the highest revenue contributor throughout the forecast period. Rising prevalence of the breast implants surgery is expected to fuel breast implants market in this region.

The key players operating in the field of Breast Implants worldwide include, Allergan plc. Mentor Worldwide LLC (J&J), GC Aesthetics, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Ideal Implant Incorporated, Silimed, Group Sebbib SAS, Guangzhou Wanhe Plastic Materials Co., Ltd, and HANSBIOMED CO. LTD. among others.

Increasing prevalence of breast cancer cases is driving the market for breast implants over the forecast period.

Breast implants are used a part of treatment of breast cancer. Rising prevalence of breast cancer has led to an increase in the demand for breast implants. Breast cancer is prevalent across the globe with increase in number of women being diagnosed with breast cancer. The disease is common in developed as well as developing countries across the globe. As per the Breastcancer.org, in 2018, in the U.S., nearly 266,120 new cases of invasive breast cancer are expected to be diagnosed in women along with 63,960 new cases of non-invasive breast cancer. Deaths rates due to breast cancer among the women in the US are high than other types of cancer. In 2018, nearly 40,920 women in the U.S. are expected to die due to breast cancer. The number of new cases for breast cancer in men are lesser as compared to women. Beastcancer.org stated that in 2018, about 2,550 new cases of invasive breast cancer are expected to be diagnosed in men.

Buy the complete report @ https://www.theinsightpartners.com/buy/TIPHE100000849/?opr-ss

Strategic Insights

Acquisition and agreement was observed as the most adopted strategy in global breast implants industry. Few of the recent acquisition and agreement are listed below:

2016: Sientra acquired Specialty Surgical Products, Inc. (SSP), with this acquisition the company will enhance it product portfolio of Dermaspan and AlloX2 lines of breast tissue expanders products.

2016: Sientra signed service agreement with Vesta, a Lubrizol LifeSciences company. Under this agreement Vesta is inaugurating manufacturing unit for Sientra and serve a long-term supply agreement for its PMA-approved breast implants.

2017: Allergan acquired LifeCell Corporation which is a regenerative medicine company. The acquisition will combine regenerative medicines business, LifeCell's novel with the Allergan’s products such as breast implants and tissue expanders and medical aesthetics.

2017: Allergan acquired Keller Medical, Inc. is a medical device company which develops Keller Funnel. The Keller will combine Keller Funnel with Allergan’s breast implants business.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.